Celltrion Inc (068270) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.013x

Based on the latest financial reports, Celltrion Inc (068270) has a cash flow conversion efficiency ratio of 0.013x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩238.15 Billion ≈ $161.39 Million USD) by net assets (₩17.81 Trillion ≈ $12.07 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 068270 net asset quality score to measure how much of total assets are equity-financed.

Celltrion Inc - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Celltrion Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 068270 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Celltrion Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Celltrion Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SIKA AG UNSP.ADR O.N. F:SIKB	N/A
ACS Actividades de Construccion y Servicios SA MC:ACS	0.330x
Ecopetrol SA ADR NYSE:EC	0.061x
FRESENIUS SE+CO. ADR 1/4 F:FREA	0.068x
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A SHE:300760	0.076x
Amrize Ltd NYSE:AMRZ	0.066x
Lens Technology Co Ltd SHE:300433	-0.003x
Dover Corporation NYSE:DOV	0.026x

Annual Cash Flow Conversion Efficiency for Celltrion Inc (2007–2025)

The table below shows the annual cash flow conversion efficiency of Celltrion Inc from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 068270 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩17.35 Trillion ≈ $11.76 Billion	₩646.05 Billion ≈ $437.82 Million	0.037x	-27.43%
2024-12-31	₩17.58 Trillion ≈ $11.91 Billion	₩901.87 Billion ≈ $611.18 Million	0.051x	+63.56%
2023-12-31	₩17.13 Trillion ≈ $11.61 Billion	₩537.16 Billion ≈ $364.02 Million	0.031x	+15424.89%
2022-12-31	₩4.27 Trillion ≈ $2.90 Billion	₩863.53 Million ≈ $585.20K	0.000x	-99.91%
2021-12-31	₩4.05 Trillion ≈ $2.74 Billion	₩911.16 Billion ≈ $617.48 Million	0.225x	+119.83%
2020-12-31	₩3.43 Trillion ≈ $2.32 Billion	₩350.75 Billion ≈ $237.70 Million	0.102x	-37.98%
2019-12-31	₩2.87 Trillion ≈ $1.95 Billion	₩473.99 Billion ≈ $321.22 Million	0.165x	+17.38%
2018-12-31	₩2.60 Trillion ≈ $1.76 Billion	₩364.79 Billion ≈ $247.21 Million	0.141x	-30.28%
2017-12-31	₩2.41 Trillion ≈ $1.63 Billion	₩485.98 Billion ≈ $329.34 Million	0.202x	+76.71%
2016-12-31	₩2.20 Trillion ≈ $1.49 Billion	₩250.89 Billion ≈ $170.02 Million	0.114x	+166.21%
2015-12-31	₩1.81 Trillion ≈ $1.23 Billion	₩77.57 Billion ≈ $52.57 Million	0.043x	-60.21%
2014-12-31	₩1.35 Trillion ≈ $913.37 Million	₩145.16 Billion ≈ $98.37 Million	0.108x	-14.59%
2013-12-31	₩1.09 Trillion ≈ $736.73 Million	₩137.08 Billion ≈ $92.90 Million	0.126x	+531.44%
2012-12-31	₩1.05 Trillion ≈ $711.67 Million	₩20.97 Billion ≈ $14.21 Million	0.020x	-71.38%
2011-12-31	₩899.55 Billion ≈ $609.61 Million	₩62.76 Billion ≈ $42.53 Million	0.070x	+61.96%
2010-12-31	₩779.89 Billion ≈ $528.52 Million	₩33.60 Billion ≈ $22.77 Million	0.043x	-72.63%
2009-12-31	₩285.67 Billion ≈ $193.60 Million	₩44.95 Billion ≈ $30.46 Million	0.157x	-26.10%
2008-12-31	₩219.72 Billion ≈ $148.90 Million	₩46.79 Billion ≈ $31.71 Million	0.213x	+117.06%
2007-12-31	₩26.59 Billion ≈ $18.02 Million	₩2.61 Billion ≈ $1.77 Million	0.098x	--

About Celltrion Inc

KO:068270 Korea Biotechnology

Market Cap

$26.76 Billion

₩39.49 Trillion KRW

Market Cap Rank

#995 Global

#18 in Korea

Share Price

₩172200.00

Change (1 day)

+1.23%

52-Week Range

₩159400.00 - ₩248500.00

All Time High

₩389079.95